Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manja Meggendorfer

Showing results (21-30 of 125) with videos related to

Pageof 13
Sort By:
Chromosoma|March 15, 2012
Stably integrated and expressed retroviral sequences can influence nuclear location and chromatin condensation of the integration locusJens Nagel, Birgit Gross, Manja Meggendorfer, et al.
Haematologica|April 23, 2016
Ultra-deep sequencing leads to earlier and more sensitive detection of the tyrosine kinase inhibitor resistance mutation T315I in chronic myeloid leukemiaConstance Baer, Wolfgang Kern, Sarah Koch, et al.
Leukemia|October 19, 2022
SF3B1 mutated MDS: Blast count, genetic co-abnormalities and their impact on classification and prognosisSandra Huber, Torsten Haferlach, Manja Meggendorfer, et al.
Leukemia Research|January 17, 2015
AML with gain of chromosome 8 as the sole chromosomal abnormality (+8sole) is associated with a specific molecular mutation pattern including ASXL1 mutations in 46.8% of the patientsTamara Alpermann, Claudia Haferlach, Christiane Eder, et al.
Blood Advances|November 4, 2020
Whole transcriptome sequencing detects a large number of novel fusion transcripts in patients with AML and MDSAnna Stengel, Rabia Shahswar, Torsten Haferlach, et al.
Blood Advances|November 21, 2018
<i>NPM1</i> mutated AML can relapse with wild-type <i>NPM1</i>: persistent clonal hematopoiesis can drive relapseAlexander Höllein, Manja Meggendorfer, Frank Dicker, et al.
Annals of Hematology|April 27, 2025
Molecular predictors of venous and arterial thrombotic events in patients with myelofibrosisOlga Morath, Jenny Rinke, Annabell Walter, et al.
Cancer Gene Therapy|February 11, 2022
Aberrant somatic hypermutation of CCND1 generates non-coding drivers of mantle cell lymphomagenesisHeiko Müller, Wencke Walter, Stephan Hutter, et al.
Leukemia|September 28, 2024
Characterization of myeloproliferative neoplasms based on genetics only and prognostication of transformation to blast phaseWencke Walter, Niroshan Nadarajah, Stephan Hutter, et al.
Science Signaling|December 25, 2014
RAS signaling promotes resistance to JAK inhibitors by suppressing BAD-mediated apoptosisPeter S Winter, Kristopher A Sarosiek, Kevin H Lin, et al.
Pageof 13

Showing results (21-30 of 125) with videos related to

Sort By:
Pageof 13
Chromosoma|March 15, 2012
Stably integrated and expressed retroviral sequences can influence nuclear location and chromatin condensation of the integration locusJens Nagel, Birgit Gross, Manja Meggendorfer, et al.
Haematologica|April 23, 2016
Ultra-deep sequencing leads to earlier and more sensitive detection of the tyrosine kinase inhibitor resistance mutation T315I in chronic myeloid leukemiaConstance Baer, Wolfgang Kern, Sarah Koch, et al.
Leukemia|October 19, 2022
SF3B1 mutated MDS: Blast count, genetic co-abnormalities and their impact on classification and prognosisSandra Huber, Torsten Haferlach, Manja Meggendorfer, et al.
Leukemia Research|January 17, 2015
AML with gain of chromosome 8 as the sole chromosomal abnormality (+8sole) is associated with a specific molecular mutation pattern including ASXL1 mutations in 46.8% of the patientsTamara Alpermann, Claudia Haferlach, Christiane Eder, et al.
Blood Advances|November 4, 2020
Whole transcriptome sequencing detects a large number of novel fusion transcripts in patients with AML and MDSAnna Stengel, Rabia Shahswar, Torsten Haferlach, et al.
Blood Advances|November 21, 2018
<i>NPM1</i> mutated AML can relapse with wild-type <i>NPM1</i>: persistent clonal hematopoiesis can drive relapseAlexander Höllein, Manja Meggendorfer, Frank Dicker, et al.
Annals of Hematology|April 27, 2025
Molecular predictors of venous and arterial thrombotic events in patients with myelofibrosisOlga Morath, Jenny Rinke, Annabell Walter, et al.
Cancer Gene Therapy|February 11, 2022
Aberrant somatic hypermutation of CCND1 generates non-coding drivers of mantle cell lymphomagenesisHeiko Müller, Wencke Walter, Stephan Hutter, et al.
Leukemia|September 28, 2024
Characterization of myeloproliferative neoplasms based on genetics only and prognostication of transformation to blast phaseWencke Walter, Niroshan Nadarajah, Stephan Hutter, et al.
Science Signaling|December 25, 2014
RAS signaling promotes resistance to JAK inhibitors by suppressing BAD-mediated apoptosisPeter S Winter, Kristopher A Sarosiek, Kevin H Lin, et al.
Pageof 13